OGN 抗体 (AA 21-298) (HRP)
Quick Overview for OGN 抗体 (AA 21-298) (HRP) (ABIN7159820)
抗原
See all OGN 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 21-298
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Mimecan protein (21-298AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - OGN (Osteoglycin (OGN))
- 
                                            别名
- OGN
- 
                                            背景
- 
                        Background: Induces bone formation in conjunction with TGF-beta-1 or TGF-beta-2. Aliases: Corneal keratan sulfate proteoglycan antibody, DKFZP586P2421 antibody, MIME_HUMAN antibody, Mimecan antibody, Mimecan proteoglycan antibody, OG antibody, OGN antibody, OIF antibody, Osteoglycin antibody, Osteoinductive factor antibody, SLRR3A antibody 
- 
                                            UniProt
- P20774
- 
                                            途径
- Glycosaminoglycan Metabolic Process
 抗原
- 
                    
 
                                     
                                     
                                    